New evidence establishes EPA as highly predictive of skin graft failure and supports the utility of Systagenix WOUNDCHEK™ Protease Status point of care test in this application

New evidence to be presented in Systagenix symposium at EWMA 2013 confirms EPA to be highly predictive of skin graft failure

Systagenix and Sorbion announce strategic partnership for super absorbent wound dressings

Systagenix & Team Sky extend their sponsorship agreement

Winners of JWC Awards announced

PROMOGRAN^®/PROMOGRAN PRISMA^® Case Studies

Wound care and the value of protease testing

Systagenix sponsors JWC Awards 2013

JWC Awards shortlist announced

The role of EPA detection in the management of chronic diabetic wounds

Systagenix begins pilot with ToolsGroup to optimise inventory levels

World Diabetes Day Report: Available Now

Systagenix awarded 2 prizes 2012 Sussex Business Awards

Gargrave Sterilisation Services...

Systagenix Announce: WUWHS 2012 Future Innovation in Woundcare Award!

Systagenix launches new wound care products in Brazil

Systagenix Wound Care Revolution Video

Team Sky lead the way in treating road rash...

Systagenix acquires O2 Insights Inc...

Systagenix EWMA 2012

New consensus on appropriate usage of silver wound dressings launched

Systagenix presents new evidence at EWMA 2012...

Systagenix Announces Milestone with WOUNDCHEK™ Protease Status

WOUNDCHEK™ Protease Status in the Independent

Systagenix wins 2012 Award for Innovation and Technology...

Systagenix sponsors WUWHS 2012 Future Innovation in Woundcare Award

Systagenix to launch EPIFIX^® amniotic membrane allograft for acute and chronic wounds

UK’s National Health Service (NHS) recommends assessment for elevated protease activity using diagnostic test to help decide Venous Leg Ulcers treatment pathway

Tissue Viability Service at Brentwood Community Hospital is First to Purchase New Test for Wounds

Ernest Waaser talks to OWM

Systagenix announces CE mark and first commercial shipment of WOUNDCHEK™ Protease Status, making it the world’s first point-of-care diagnostic test for chronic wounds

Systagenix shortlisted for Innovation and New Technology in Business and New Business of the Year 2012 in Gatwick Diamond Business Awards

Systagenix shortlisted for CCA excellence award

Systagenix announces launch of world’s first point of care test for the assessment of chronic wounds

Systagenix Wound Management (Germany) GmbH and TRIGOcare GmbH enter partnership agreement to meet market demands

Systagenix awarded contact centre team of the year: B2B in CCA excellence awards

Systagenix announces addition to board of directors

Treating Juan Antonio Flecha after that crash: using the range of Systagenix dressings

Wound care experts agree protease test could change wound care globally

Systagenix sponsors virtual conference with Wounds International

Product evaluation validates the clinical effectiveness of ADAPTIC TOUCH^®

Sky riders healing quicker with ADAPTIC TOUCH^®

Huge benefits from partnership with Systagenix

Team Sky Hugely Impressed with Systagenix’s TIELLE^® Lite Dressings

Systagenix leading the way in wound assessment and wound diagnosis

Healthpoint acquires Regranex gel from Systagenix

Systagenix announces new CEO

Team Sky Tech Channel

Systagenix Launches ADAPTIC TOUCH^®

Systagenix at Gargrave

Products Manufactured at Gargrave

Systagenix Wound Management awarded research grant

SKY PRO CYCLING Appoint Systagenix

Systagenix steps up in the world of wound healing by launching their new brand identity

Systagenix Celebrates 75 years of Pioneering Woundcare

Introducing Systagenix Wound Management

Systagenix appoints leading wound care specialist as medical director

Systagenix unveils SILVERCEL^® NON-ADHERENT silver hydro alginate dressing

Systagenix appoints president of europe as it drives to expand its european wound care business

Systagenix opens prestigious head office at the gateway to the world

Systagenix announces formation of new global medical advisory board